Organogenesis Holdings, Inc. (ORGO)
0.7892
-0.06
(-7.50%)
USD |
NASDAQ |
Nov 19, 16:00
0.7945
+0.01
(+0.67%)
Pre-Market: 20:00
Organogenesis Holdings Cash from Operations (Quarterly) : -18.59M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -18.59M |
| June 30, 2026 | -31.65M |
| March 31, 2026 | 21.13M |
| December 31, 2025 | 39.42M |
| September 30, 2025 | 3.079M |
| June 30, 2025 | -32.87M |
| March 31, 2025 | -19.94M |
| December 31, 2024 | 10.94M |
| September 30, 2024 | 8.695M |
| June 30, 2024 | 4.738M |
| March 31, 2024 | -10.16M |
| December 31, 2023 | 10.61M |
| September 30, 2023 | 16.74M |
| June 30, 2023 | 8.646M |
| March 31, 2023 | -5.077M |
| December 31, 2022 | 7.80M |
| September 30, 2022 | 5.453M |
| June 30, 2022 | 10.20M |
| March 31, 2022 | 1.411M |
| December 31, 2021 | 17.95M |
| Date | Value |
|---|---|
| September 30, 2021 | 27.85M |
| June 30, 2021 | 17.66M |
| March 31, 2021 | -1.479M |
| December 31, 2020 | 23.22M |
| September 30, 2020 | 8.869M |
| June 30, 2020 | -9.335M |
| March 31, 2020 | -17.28M |
| December 31, 2019 | -6.401M |
| September 30, 2019 | -5.453M |
| June 30, 2019 | -12.12M |
| March 31, 2019 | -9.558M |
| December 31, 2018 | -60.02M |
| September 30, 2018 | -0.2867M |
| June 30, 2018 | -0.2101M |
| March 31, 2018 | -0.2264M |
| December 31, 2017 | -0.0918M |
| September 30, 2017 | -0.1687M |
| June 30, 2017 | -0.1997M |
| March 31, 2017 | -0.1263M |
| December 31, 2016 | 0.0078M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| cbdMD, Inc. | -0.4422M |
| Guardian Pharmacy Services, Inc. | 43.37M |
| Lineage Cell Therapeutics, Inc. | -5.62M |
| Tenax Therapeutics, Inc. | -12.48M |
| Heron Therapeutics, Inc. | -0.794M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 2.146M |
| Cash from Financing (Quarterly) | -3.459M |
| Free Cash Flow | -0.064M |
| Free Cash Flow Per Share (Quarterly) | -0.1555 |
| Free Cash Flow to Equity (Quarterly) | -17.63M |
| Free Cash Flow to Firm (Quarterly) | -20.00M |
| Free Cash Flow Yield | -0.06% |